COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
(±)-Anatoxin A fumarate (HB2023)
Description:Potent nicotinic agonist. Apoptosis inducer.
Purity:>99%
-
Dihydroanatoxin-A fumarate (dhATX) (HB7494)
Description:Less toxic, degradation product of Anatoxin-A
Purity:>95% (NMR)
-
Ivermectin (IVM) (HB1958)
Description:α7 nicotinic acetylcholine receptor positive allosteric modulator. Activates GluCI/GlyCI chemogenetic channels. Shows antiviral activity.
Purity:>95%
-
Methyllycaconitine citrate (MLA) (HB2026)
Description:Potent, selective α7 nicotinic receptor antagonist
Purity:>95%
-
(+)-Tubocurarine chloride (HB2050)
Description:Nicotinic acetylcholine receptors (nACHR) antagonist. Neuromuscular blocker.
Purity:>98%
-
Varenicline tartrate (HB2070)
Description:Selective α4β2 nAChR partial agonist; orally active
Purity:>99%
